Injections vs Oral or Sublingual GLP-1: What to Know

For a lot of readers the deciding question is not which molecule or which provider — it is whether they have to use a needle. Oral and sublingual GLP-1 options exist and are marketed hard, but the route you pick has real consequences for both convenience and the strength of the evidence behind your treatment. Here is how the Desk weighs it.

The injectable route: where the evidence lives

The pivotal weight-management trials studied injectable products. Wegovy is a once-weekly subcutaneous injection of semaglutide 2.4 mg³; Zepbound is a once-weekly subcutaneous injection of tirzepatide⁴. Those are the exact forms behind the headline results — roughly 15% mean weight loss for semaglutide over 68 weeks¹ and up to about 21% for tirzepatide². If you want the treatment that matches the trial evidence most closely, the weekly injection is it.

The practical downside is obvious: it is a shot. Most patients self-administer with a small subcutaneous needle once a week, which is a genuine barrier for the needle-averse even though the technique is simple.

The oral and sublingual route: convenience, less data

Oral tablets and sublingual (under-the-tongue) drops or troches are offered by a number of providers on our board, usually as compounded formulations. Their appeal is straightforward — no needles, and an easy daily routine.

The honest caveat is about evidence. The large weight-management trials the whole category cites were run on injectable products, not on compounded oral or sublingual formulations. That means the specific weight-loss figures you see advertised should not be assumed to carry over one-to-one to a needle-free compounded route; the comparable trial data simply is not part of the approved evidence base. Treat needle-free options as a convenience trade-off, and ask any provider directly what dosing and formulation they use.

How to decide

Choose the **weekly injection** if:

- You want the route that matches the pivotal trial evidence. - Maximizing expected weight loss is the priority. - A weekly self-injection is something you can live with.

Choose an **oral or sublingual** option if:

- Needle aversion is a real barrier to starting or staying on treatment. - You accept that the convenience comes with a thinner evidence base. - You have vetted the compounding pharmacy — see is compounded GLP-1 legit and safe.

Finding a provider for either route

If you want the injectable path, the top of our board is built for it: CoreAge Rx carries both injectable molecules with a flat all-in price nationwide. If needle-free is the requirement, filter to providers that carry oral or sublingual formats — Vaylen offers both routes plus brand access, Curex carries oral options at one price for either molecule, and ShedRx is built specifically around needle-free and sublingual delivery. Our best GLP-1 provider by need guide sorts the full field by route, and you can line up any two providers on the comparison desk. Still choosing the drug itself? Read semaglutide vs tirzepatide.